Clinical Trials Browser

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT06189482 2024-03-12

NPC

Phase NA Terminated

56 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Deglutition Disorders

NCT03544099 2023-04-11

Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA

Phase 2 Terminated

2 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02582008 2023-03-22

Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Phase EARLY_PHASE1 Terminated

9 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma

NCT02874651 2022-01-11

ADVANCE

Phase 2 Terminated

25 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT02801487 2020-02-17

Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Phase 1/2 Terminated

6 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02789189 2019-09-06

Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail

Phase 2 Terminated

60 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT00484601 2019-02-11

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Phase 2 Terminated

9 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03049358 2019-02-05

Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer

Phase NA Terminated

15 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Paranasal Sinus Neoplasms

NCT02058017 2015-06-19

OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy

Phase 1 Terminated

9 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01694576 2015-06-15

NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation

Phase 2 Terminated

10 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00201344 2010-03-26

A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma Patients

Phase 3 Terminated

320 enrolled

Head & Neck

Nasopharyngeal Carcinoma

Clinical Trials

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

NPC

Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA

Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

ADVANCE

Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer

OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy

NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation

A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma Patients